South Rampart Pharma
South Rampart Pharma, Inc. is a clinical-stage life science biotechnology company dedicated to advancing safer pain treatments by developing best-in-class novel small molecule analgesics designed to overcome the risks associated with current pain medicines. The Company's pipeline of novel compounds has effectively reduced pain and fever in preclinical studies without the liver and kidney toxicities of current non-opioid analgesics. The Company's lead program, SRP-001, is a first-in-class analgesic with FDA Fast Track Designation that targets the midbrain's PAG region without opioid abuse potential or acetaminophen's liver toxicity.Content by South Rampart Pharma
Page 1 of 1 - 1 Total Items
